--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, presented data today from a study showing that its methylation-based Shield™ multi-cancer detection ...

Investigators shared real-world data showing a clear and consistent association between increased tumor size and mortality ...